Freudenberg Expands Bioprocessing Capabilities at CPHI and PMEC India
The global manufacturer has introduced its CleanAssure system, a cleanroom-based sanitary washing and drying workstation that uses ultra-purified water and filtered air to enhance safety for single-use tubings and assemblies.
Biotechnology | 25/11/2025 | By Darshana
India Unveils its First Indigenous CRISPR-based Gene Therapy 'BIRSA 101' for Sickle Cell Disease
India has formally begun its decisive journey towards becoming a Sickle Cell Disease–free nation, with Union Minister of State for Science & Technology Dr. Jitendra Singh launching the country's first indigenous CRISPR-based gene therapy for the condition.
Biotechnology | 20/11/2025 | By Dineshwori | 224
EirGenix Signs Second Global Licensing Deal With Sandoz for Pertuzumab Biosimilar
EirGenix Inc., a Taiwan-based biopharmaceutical and CDMO company, has signed a second global exclusive licensing agreement with Sandoz AG for the commercialization of its pertuzumab biosimilar EG1206A, developed as an alternative to Roche’s Perjeta.
Biotechnology | 14/11/2025 | By Darshana | 104
Dyadic International, Inc. (operating as Dyadic Applied BioSolutions), a US-based biotechnology innovator, has appointed international business development consultancy Intralink to expand its commercial presence in Japan and South Korea — two of Asia’s fastest-growing and most advanced biopharmaceutical markets.
Biotechnology | 10/11/2025 | By Darshana | 111
Bharat Biotech Launches Nucelion, a New CRDMO Focused on Cell and Gene Therapies
The new entity, based in Genome Valley, Hyderabad, is designed to partner with global life-science innovators to deliver end-to-end solutions for complex biologic medicines.
Biotechnology | 03/11/2025 | By Darshana | 260
FDA Grants Tentative Approval to Amneal Pharmaceuticals' Generic Version of QVAR Inhalation Aerosol
Beclomethasone dipropionate HFA inhalation aerosol is a corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in patients aged five years and older. It is not indicated for the relief of acute bronchospasm.
Biotechnology | 31/10/2025 | By Darshana | 117
Medinet Japan partners with India's Stempeutics for Stempeucel cell therapy to treat CLTI
Medinet Co., Ltd, a Tokyo-listed regenerative medicine and CDMO company, has signed an option licence agreement with India-based Stempeutics Research for the development and commercialisation of its Stempeucel therapy in Japan, targeting Chronic Limb Threatening Ischaemia (CLTI).
Biotechnology | 29/10/2025 | By Darshana | 160
DPIIT and Thermo Fisher Scientific Sign MoU to Strengthen India's Biotech Startup Ecosystem
The partnership between DPIIT and Thermo Fisher Scientific to support 500+ biotech startups through advisory, mentorship and nationwide challenge.
Biotechnology | 04/10/2025 | By Dineshwori | 174
Alkem Launches Pertuzumab Biosimilar Pertuza in India for HER2-Positive Breast Cancer
Alkem Laboratories has introduced Pertuza, a biosimilar of pertuzumab, in India for the treatment of HER2-positive breast cancer. The drug is supplied as a 420 mg/14 mL injection and is developed and manufactured domestically.
Biotechnology | 23/09/2025 | By Darshana | 234
Abzena Enhances AbZelectPRO Cell Line Offering with New GS Knockout Platforms
Named AbZelectPRO-KO and AbZelectPRO-KO+, the new GS knockout platforms are available as a stand-alone CLD offering, or as a fully integrated GMP programme, with fully transparent pricing to IND with no royalty fees. This flexible offering will enable customers to select a CLD strategy that aligns with their project-specific goals, timeline and budget.
Biotechnology | 15/09/2025 | By Dineshwori | 168
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy